Skip to content

Longevity

Glutathione

Also called GSH

InjectableEvidence B2x per week
Half-life
0.1hours
Typical vial
200 / 600mg
Research amounts
600–2000mg

per administration

Common schedule
2x per week
Some human use

It has been used in people, but no trial has settled how much or how often.

The human evidence for Glutathione used the intravenous route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded900units dialled
Concentration
66.67mg/mL
Volume per draw
9mL
Units to dial
900
Doses per cartridge
0

This is 900 units, past the 60-unit dial. Splitting it across administrations, or using less water to raise the concentration, brings it back into range.

Dial range varies by pen; 1–60 units is the common configuration.

Vial label

Copy this into your label printer.

Published research contexts for Glutathione describe 6002000 mg per administration. Descriptive only, not a recommendation.

Cleared within minutes after an intravenous dose, so the decay chart is mostly illustrative here.

A tripeptide (γ-Glu-Cys-Gly) given intravenously in small human studies, but no trial fixes a dose-ranging schedule; the circulating amounts are not trial-established, so no schedule table is shown.

Modelled level — 2x per week

1× is the peak after a single dose.

Steady-state peak
0.97× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
1hours

About five half-lives

Administrations
2/ week

Where these numbers come from

  • Intravenous glutathione literatureSmall intravenous human studies report exposure and tolerability without settling a dose-ranging schedule.

Next steps